Home › NCT02168088
Molecular Autopsy Study
RecruitingObservational study
Molecular Autopsy for Sudden Cardiovascular Death
Who can join
Up to age 45 · All sexes
Full eligibility criteria
Inclusion Criteria: * Index case age between birth - 45 years * Clinical presentation of sudden / unexplained death (believed to be cardiac in nature OR secondary to a massive unprovoked pulmonary embolism with no prior diagnosis of prothrombotic disease) Exclusion Criteria: * Premature death secondary to murder, suicide or external causal event * Premature death thought secondary to known chronic comorbid medical condition * Premature death thought secondary to end-organ failure (kidney, liver, lung) other than heart * Previously diagnosed with hypertrophic cardiomyopathy (HCM) * Prior myocardial infarction (regardless of stenting or bypass) * Prior cerebrovascular accident (stroke or TIA) * History of open heart surgery (for any reason) * History of severe, untreated hypertensive heart disease * History of illicit drug use * History of heavy alcohol abuse * History of severe pulmonary disease * History of morbid obesity
About the study
This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death.
Sponsor: Scripps Translational Science Institute · Participants: 100 · Started: 2014-06
Contact the study team
- Sarah Topol, RN · Phone: 858-784-2155
- Emily Spencer, Phd · Phone: 858-784-2029
Official record on ClinicalTrials.gov — NCT02168088
Locations in the U.S.
| California | Scripps Translational Science Institute, La Jolla |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.